Presentations

Presentations Title Event Location Date
David J. Rawlings, MD Altered B Cell Signaling Orchestrates Loss of Tolerance and Systemic Autoimmunity University of Washington, Amgen Symposium Seattle, WA Nov. 7, 2013
David J. Rawlings, MD New Insights into Normal and Dysregulated B Cell Function Jeffrey Modell Centers Summit Berlin, Germany July 17, 2013 - July 20, 2013
Andrew M. Scharenberg, MD High Efficiency Genome Editing Using Endonuclease/Exonuclease Co-expression 2013 American Society of Gene Therapys (ASGCT) 16th Annual Meeting Salt Lake City, UT May 2013
David J. Rawlings, MD Updates in Gene Therapy for PID Clinical Immunology Society Annual Meeting Miami, FL April 25, 2013 - April 28, 2013
David J. Rawlings, MD Seminaire dImmunologie, Hematologie et de Rhumatologie Pediatriques Pierre Royer Institut Paris, France Feb. 19, 2013 - Feb. 22, 2013
David J. Rawlings, MD A Novel, B Cell Intrinsic, IL17 B Program helps to control Trypanosoma Cruzi Infection Seattle BioMedical Research Institute Research Seminar Seattle, WA Dec. 10, 2012
Andrew M. Scharenberg, MD Genome Editing with Rare Cleaving Nucleases 2012 American Society of Gene Therapys (ASGCT) 15th Annual Meeting May 2012
David J. Rawlings, MD Clinical Insights Derived from B-Cell Immunodeficiency Disorders American Society of Hematology Meeting San Diego, CA Dec. 10, 2011 - Dec. 11, 2011
Suzanne Skoda-Smith, MD From 1952 to 2012: The Impact and Evolution of Diagnostics in Allergy and Immunology 6th Annual Alvin D. Wert Lecture in Pediatric Allergy, OHSU Portland, OR Dec. 8, 2011
Andrew M. Scharenberg, MD Genetic Editing: The Key to Future Therapies for Genetic Disease, HIV, and Cancer Research in Action Event Seattle, WA Dec. 2011
Suzanne Skoda-Smith, MD Identifying Primary Immunodeficiencies: Present and Future Legacy Continuing Medical Education: Current Topics in Pediatrics Conference Portland, OR Nov. 19, 2011
Suzanne Skoda-Smith, MD Parent Education Meeting for Persons and Families Living with Primary Immunodeficiency Diseases Immune Deficiency Foundation Seattle, WA Sept. 10, 2011
Andrew M. Scharenberg, MD Advanced Gene Modification Technologies External Scientific Advisory Board Meeting (EAB) Seattle, WA Aug. 2011
David J. Rawlings, MD A Link between Innate and Adaptive Immunity Jeffrey Modell World Immunology Conference Rockefeller University; NY June 1, 2011 - June 5, 2011
David J. Rawlings, MD Viral Vectors for Gene Targeting and Homologous Recombination in Gene Therapy ASGCT 14th Annual Meeting Seattle, WA May 18, 2011 - May 22, 2011
Suzanne Skoda-Smith, MD RASopathies and Other Shard Conditions Hematology/Oncology Friday AM Research Conference Seattle, WA May 13, 2011
David J. Rawlings, MD B Cells: New Insights into Normal versus Dysregulated Function 2011 Keystone Symposium Whistler, British Columbia, Canada April 12, 2011 - April 17, 2011
Andrew M. Scharenberg, MD Immune Reconstitution Mixed Chimerism Investigators Meeting Seattle, WA May 2010
Andrew M. Scharenberg, MD The role of BAFF in post-hematopoietic cell transplantation immune reconstitution Novo Nordisk Inc Seattle, WA March 2010
Mohamed Oukka, PhD Role of Th17 Cells in Autoimmunity 15. Department of Rheumatology, University of Washington Seattle, WA Nov. 16, 2009
Andrew Scharenberg, MD Flow Cytometry in Immunology: sample preparation, technology, applications Allergy and Immunology Fellows Didactic Lecture, Seattle Children’s Research Institute Seattle, WA Nov. 1, 2009
Suzanne Skoda-Smith, MD Non-Malignant Review Board Presentation Seattle Cancer Care Alliance Seattle, WA Sept. 2009
Mohamed Oukka, PhD Interplay Between Th17 and Regulatory T Cells in Autoimmunity Forsythe Institute Boston, Massachusetts June 4, 2009
David Rawlings, MD B Cell homeostatis and activiation IUIS Expert Meeting on Primary Immunodeficiencies Dublin, Ireland June 3, 2009
Andrew Scharenberg, MD Homing endonucleases as genome engineering reagents UCLA Human Gene Medicine Program Symposium Los Angeles, CA June 1, 2009
Mohamed Oukka, PhD Regulatory T Cells and IL-17 Producing Cells in Immunity and Autoimmunity 13. Center of Research CHUM-Notre Dame Montreal, Canada May 21, 2009
David Rawlings, MD Improving Cellular Therapy for Primary Immune Deficiency Diseases - Recognition, Diagnosis and Management NIH Workshop Bethesda, MD May 20, 2009
Andrew Scharenberg, MD Immune Reconstitution following NM-HCT Mixed Chimerism Investigators’ Meeting, Fred Hutchinson Cancer Research Center Seattle, WA May 1, 2009
Andrew Scharenberg, MD Common Variable Immune Deficiency: Overview and Case Studies Allergy Journal Club, Center of Allergy and Inflammation Seattle, WA April 1, 2009
Andrew Scharenberg, MD TRPM7 regulates quiescent-proliferative metabolic transitions in lymphocytes Amgen Symposium Seattle, WA April 1, 2009
Andrew Scharenberg, MD Engineered homing endonucleases for genome engineering applications Cellectis SA, France Paris, France March 1, 2009
Andrew M. Scharenberg, MD Engineered homing endonucleases for genome engineering applications Cellectis SA, France Paris, France March 2009
Suzanne Skoda-Smith, MD Severe Combined Immunodeficiency Disease Advance Oncology Day, Seattle Children's Hospital Seattle, WA Feb. 23, 2009
Mohamed Oukka, PhD Regulatory T Cells and IL-17 Producing Cells in Immunity and Autoimmunity 16. Department of Immunology, University of Washington Seattle, WA Jan. 23, 2009
Suzanne Skoda-Smith, MD Primary Immunodeficiency for the Hematologist/Oncologist Primary Immunodeficiency for the Hematologist-Oncologist Research Seminar, Seattle Children's Hospital Seattle, WA 2009
Suzanne Skoda-Smith, MD Severe Combined Immunodeficiency Disease Advanced Oncology Day, Seattle Children's Hospital Seattle, WA Jan. 1, 2009
Troy Torgerson, MD, PhD IPEX 44. American Autoimmune Related Diseases Association Scientific Colloquium Baltimore, MD Jan. 1, 2009
Troy Torgerson, MD, PhD Insights into FOXP3 and STAT3 transcription factor biology from human disease 43. Stanford University Immunology Program Seminar Series Palo Alto, CA Jan. 1, 2009
Troy Torgerson, MD, PhD New mutations affecting innate immunity 42. American College of Rheumatology Annual Meeting Philadelphia, PA Jan. 1, 2009
Troy Torgerson, MD, PhD Immunology dysregulation, polyendocrinopathy, enteropathy, x-linked and forkhead box P3 41. American College of Rheumatology Annual Meeting Philadelphia, PA Jan. 1, 2009
Troy Torgerson, MD, PhD New tricks from old transcription factors: FOXP3 and STAT3 in human Immunodeficiency disorders 40. Duke University Medical Center Immunology Seminar Series Durham, NC Jan. 1, 2009
Troy Torgerson, MD, PhD The association between autoimmunity and immunodeficiency disorders-tragic stories of indifference and disloyalty 39. Duke University Medical Center Pediatric Grand Rounds Durham, NC Jan. 1, 2009
Troy Torgerson, MD, PhD Immune dysregulation syndromes: single gene defects associated with severe autoimmunity 38. 5th Annual Sudhir Gupta Endowed Chair in Molecular Immunology Symposium Newport Beach, CA Jan. 1, 2009
Troy Torgerson, MD, PhD Immunology 101 & Treatment Options for PIDD 37. Immune Deficiency Foundation Lake Buena Vista, FL Jan. 1, 2009
Troy Torgerson, MD, PhD Basic Immunology 36. Immune Deficiency Foundation Lake Buena Vista, FL Jan. 1, 2009
Troy Torgerson, MD, PhD The naturally occurring splice variant of FOXP3 lacking Exon 2 is not sufficient to maintain immune homeostasis and prevent IPEX in vivo in humans. 35. Federation of Clinical Immunology Societies San Francisco, CA Jan. 1, 2009
Troy Torgerson, MD, PhD Functional consequences of FOXP3 and STAT3 mutations identified in IPEX and Hyper IgE syndrome. Northwestern University Feinberg School of Medicine Chicago, IL Jan. 1, 2009
Troy Torgerson, MD, PhD Recent scientific advances to promote early diagnosis of PID: current issues and potential solutions. Latin American Symposium Sao Paulo, Brazil Jan. 1, 2009
Troy Torgerson, MD, PhD Our daily war on terror: how the immune System protects our bodies from invaders and a look at interesting ways in which this breaks down. Idaho State University Pocatello, ID Jan. 1, 2009
Troy Torgerson, MD, PhD Failure of immune tolerance. 31. American Academy of Allergy, Asthma & Immunology, Annual Meeting Washington, D.C. Jan. 1, 2009
Troy Torgerson, MD, PhD When less is more: the conundrum of autoimmunity in immunodeficiency syndromes. 30. Immune Deficiency Foundation, Le Bien Visiting Professor Program Hershey, PA Jan. 1, 2009
Suzanne Skoda-Smith, MD Morbid/Mortality discussion on recent SCID patient Fred Hutchinson Cancer Research Center Seattle, WA Nov. 14, 2008
Andrew M. Scharenberg, MD Recurrent Infections: An Immunologist's View Northwest Allergy Forum Seattle, WA Oct. 2008
David J. Rawlings, MD Antigen receptor driven NFkB signals in B cells- distinct inputs modulate activation, tolerance, and lymphoma development 50. University of Cincinnati, Cancer and Cell Biology Seminar Series Cincinnati, OH April 23, 2008 - April 24, 2008
Andrew M. Scharenberg, MD The Northwest Genome Engineering Consortium and the Future of Gene Repair Childrens Legacy Planning Council Seattle, WA Feb. 2008
Andrew M. Scharenberg, MD The Northwest Genome Engineering Consortium: new tools for manipulating genomes; new treatments for inherited disease Biotechnology and Biomedical Association (WBBA), Frontiers in Childrens Health Seattle, WA Nov. 2007
Andrew M. Scharenberg, MD Design of novel LAGLIDADG homing endonucleases for genome engineering applications UW Institute for Stem Cell and Regnerative Medicine (ISCRM): Stem Cell Meeting Seattle Nov. 2007
Suzanne Skoda-Smith, MD Clinical Approach to Children with Immune Deficiency Disease 15th Annual Care of the Sick Child Conference Orlando, FL Nov. 2007
Andrew M. Scharenberg, MD The Northwest Genome Engineering Consortium DWT Venture Series Seattle, WA Oct. 2007
Andrew M. Scharenberg, MD Design of novel LAGLIDADG homing endonucleases for genome engineering applications UW Gene Therapy Club Meeting Seattle, WA Oct. 2007
Andrew M. Scharenberg, MD Regulation of lymphocyte biosynthetic metabolism by TRMP7 University of Washington 18th Annual Immunology Department Retreat Port Townsend, WA Sept. 2007
Andrew M. Scharenberg, MD Signaling pathways downstream of the channel/kinase TRPM7 FASEB Summer Research Conference Snowmass, CO June 2007
David J. Rawlings, MD Role of PKC Signals in B Cell Activation, Survival and Malignancy Harvard Medical School Program in Immunology Seminar Series Boston, MA May 23, 2007
Andrew M. Scharenberg, MD Use of multiparameter B-cell subset analysis for diagnosis and evaluation of humoral immunodeficiencies Molecular Diagnostic Center at Childrens Inauguration Seminar Series Seattle, WA May 2007
David J. Rawlings, MD Molecular Mechanism(s) Controlling PKC-Dependent, Immunoreceptor-Induced Signals Keystone Symposia "Biology of B Cells in Health and Disease (B5)" Banff, Alberta, Canada Feb. 6, 2007 - Feb. 11, 2007
David J. Rawlings, MD Gene Rx for WAS and XLA NIH Gene Therapy Conference, Gene Therapy for Inherited Immune Deficiencies: Advances and Safety Issues Bethesda, MD Sept. 18, 2006 - Sept. 19, 2006
Andrew M. Scharenberg, MD Dual Function Ion/Channel Kinases Regulate Cell Growth Frontiers in Science/AMPSDC Meeting Phoenix, AZ March 2006
David J. Rawlings, MD Gene Therapy of Primary Immunodeficiency Disorders UW Cystic Fibrosis Research Seminar Series Seattle, WA Dec. 22, 2005
David J. Rawlings, MD Distinct signaling responses of transitional B cell subsets and their developmental consequences 7th Latin American Congress of Immunology Cordoba, Argentina Oct. 2, 2005 - Oct. 6, 2005
Andrew M. Scharenberg, MD TRPM2 and TRPM7 ion channels as drug targets IBC Ion channels as drug targets conference Bellevue, WA Oct. 2005
Andrew M. Scharenberg, MD TRPM ion channels as drug targets Aurora Biomed Conference on Ion channels and Transporters as Drug Targets Vancouver, BC June 2005
Suzanne Skoda-Smith, MD Antibiotic and Antifungal Therapy in Primary Immune Deficiency Immune Deficiency Foundation 3rd National Conference Orlando, FL June 2005
David J. Rawlings, MD Btk-dependent events controlling calcium and NF-kB signaling in B lymphocytes 3rd Lymphocyte Signal Transduction Workshop Crete, Greece May 27, 2005 - June 1, 2005
David J. Rawlings, MD Regulation of CARMA1-mediated NF-B signaling via PKC isoforms in B and T lymphocytes Cantoblanco Workshops Madrid, Spain May 22, 2005 - May 24, 2005
David J. Rawlings, MD Molecular Mechanism(s) Controlling PKC-Dependent, Immunoreceptor-Induced NF-kappaB Activation Keystone Symposia Steamboat Springs, Colorado March 28, 2005 - April 3, 2005
Andrew M. Scharenberg, MD Molecular mechanisms of Magnesium Homeostasis Gordon Conference on Magnesium Ventura, CA Feb. 2005
Andrew M. Scharenberg, MD Molecular Analysis of Mg2+ homeostasis University of Toronto Neuroscience Group Seminar Series Toronto, CA Nov. 2004
David J. Rawlings, MD Preclinical Gene Therapy Studies in XLA and WAS NIH Conference on Wiskott-Aldrich Syndrome Gene Therapy for Wiskott-Aldrich Syndrome Bethesda, MD Sept. 22, 2004 - Sept. 23, 2004
David J. Rawlings, MD Gene Therapy for Immunodeficiency Disease Progress, Challenges and Coming Trials Childrens Hospital and Regional Medical Center Seattle, Grand Aug. 8, 2004
David J. Rawlings, MD The Role of BtK in B Cell Activation 12th International Congress of Immunology and 4th Annual Conference of FOCIS Montreal, Canada July 18, 2004 - July 23, 2004
David J. Rawlings, MD Molecular Events Controlling B Cell Receptor Dependent NfkappaB Activation Amgen Inc. and the University of Washington Department of Immunology Eighth Annual Joint Immunology Symposium Seattle, WA May 21, 2004
Andrew M. Scharenberg, MD TRPM channel/enzymes Genentech post-doctoral fellow speaker series Feb. 2004
David J. Rawlings, MD Untangling the Pathways for Lymphocyte Activation American Association of Immunologists May 2003
Andrew M. Scharenberg, MD Mammalian Trp Channel as Molecular Targets Nobartis Foundation Symposium London, UK March 2003
Andrew M. Scharenberg, MD Ion channels as enzymes: structure and function of TRPM ion channels PAS/SPR Meeting National Young Investigator Award Baltimore, MD 2002
Suzanne Skoda-Smith, MD Peripheral Blood Stem Cell Transplantation for Severe Combined Immunodeficiency Disease Children's Hospital of Cincinnati, Division of Pediatric Hematology and Oncology Cincinnati, OH Jan. 2002
Suzanne Skoda-Smith, MD Clues in the Diagnosis of Primary Immunodeficiency American College of Osteopathic Pediatricians Spring Convention Naples, FL June 2001
Andrew M. Scharenberg, MD A novel family of cation channels expressed in immune system cells Antigen Receptor Signaling Siena, Italy April 2000
Suzanne Skoda-Smith, MD Emerging Infectious Diseases 29th Annual Florida Pediatric Alumni Association Meeting Amelia Island, GA April 1998
Suzanne Skoda-Smith, MD Invited speaker Immune Deficiency Foundation regional conferences 1998 - 2005